Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias (TRAIN-AD)
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias (TRAIN-AD)
Sponsor: Hebrew SeniorLife
This NA trial investigates Dementia and Infection, Bacterial and is currently completed. Hebrew SeniorLife leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2021 — Sep 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Aug 2019 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hebrew SeniorLife
For direct contact, visit the study record on ClinicalTrials.gov .